S&P 500
5,963.60
+0.1%
+5.22
DJI
42,792.07
+0.3%
+137.33
NASDAQ
19,215.46
+0.0%
+4.36
Bitcoin
105,879.00
+1.8%
+1,850.64
AAPL
$208.78
-1.2%
-$2.48
AMZN
$205.97
+0.2%
+$0.38
GOOG
$167.77
+0.2%
+$0.34
META
$640.00
-0.1%
-$0.34
MSFT
$458.29
+0.9%
+$4.02
NVDA
$135.42
+0.0%
+$0.02
TSLA
$341.81
-2.3%
-$8.17
Scinai Immunotherapeutics (NASDAQ: BVXV)
$2.72
(7.1%)
$0.18
Price as of May 13, 2025, 2:35 p.m. ET
Scinai Immunotherapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Scinai Immunotherapeutics Company Info
BiondVax Pharmaceuticals Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. It focuses on the flu vaccine candidate that was designed to provide multi-strain and multi-season protection against seasonal and pandemic influenza. The company was founded by Ronald Babecoff and Rami Epstein on July 21, 2003 and is headquartered in Jerusalem, Israel.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.